Shares at Hims & Hers Health were down 9%, extending losses from last week after the Food and Drug Administration determined that a shortage of popular weight-loss drugs Wegovy and Ozempic had ...

TD Cowen expects the company to be neck and neck in the weight loss drugs market with its semaglutide-based products Wegovy and Ozempic ... compute & networking and graphics solutions provider ...

Him & Hers produces versions of Novo’s Ozempic and Wegovy. As a result ... tried to ride the artificial intelligence boom. However, graphics chips power the AI market, whereas quantum computing ...

Time for your weekly edition of the Defector Funbag. Got something on your mind? Email the Funbag. And buy Drew’s book, The Night The Lights Went Out, while you’re at it. Today, we’re talking about ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now. By Rebecca Robbins It’s easy to make a medical case for ...

State lawmakers are considering expanding the types of obesity treatments covered by Nevada Medicaid, including approving ...

Novo Nordisk A/S is following in rival Eli Lilly & Co.’s footsteps by selling its hit weight-loss drug Wegovy directly to US patients at a discount. The Danish drugmaker launched NovoCare ...

For eligible patients, health care providers can send Wegovy prescriptions directly to NovoCare Pharmacy. Novo Nordisk is providing direct-to-patient delivery of Wegovy ® (semaglutide ...

The Food and Drug Administration announced Friday it had officially declared an end to the nationwide shortage of Ozempic and Wegovy, medications used for diabetes and weight loss. The agency ...

The Food and Drug Administration on Friday said the shortage of Novo Nordisk's weight-loss and diabetes drugs Wegovy and Ozempic is resolved, a move that could limit the availability of cheaper ...